Non-Current Liabilities

Finance Lease Liabilities

West Pharmaceutical Services Finance Lease Liabilities decreased by 8.3% to $3.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.5%, from $3.10M to $3.30M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ1 2026

How to read this metric

High levels indicate significant reliance on leased assets for operations, which serves as a form of off-balance-sheet-style financing.

Detailed definition

This represents the total long-term obligations under finance leases, excluding the current portion. It reflects the com...

Peer comparison

Used to compare capital intensity and financing strategies across peers.

Metric ID: finance_lease_liabilities

Historical Data

10 periods
 Q4 '21Q4 '22Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$2.40M$2.20M$2.10M$3.10M$3.60M$3.90M$3.60M$3.30M
QoQ Change-8.3%-4.5%+47.6%+16.1%+8.3%-7.7%-8.3%
YoY Change+50.0%+77.3%+71.4%+6.5%
Range$0.00$3.90M
Avg YoY Growth+51.3%
Median YoY Growth+60.7%
Current Streak2 quarters decline

Frequently Asked Questions

What is West Pharmaceutical Services's finance lease liabilities?
West Pharmaceutical Services (WST) reported finance lease liabilities of $3.30M in Q1 2026.
How has West Pharmaceutical Services's finance lease liabilities changed year-over-year?
West Pharmaceutical Services's finance lease liabilities increased by 6.5% year-over-year, from $3.10M to $3.30M.
What does finance lease liabilities mean?
Total long-term debt obligations related to finance leases.